A Second, Silent Pandemic: Antibiotic Resistance

  21 October 2021

Recent studies have shown a worrying overuse of antibiotics while treating COVID-19 patients, despite low co-infection rates. Globally, around 80% of  hospitalized COVID-19 patients receive prophylactic antibiotics, which could lead to a rise in drug-resistant infections. And in places like Lebanon, COVID-19 has contributed to a rollback of antibiotic regulations, making it once again possible to access a wide range of antibiotics without prescription.

A second, silent pandemic is spreading before our eyes as more bacteria are becoming resistant to antibiotics. If we continue down the current path, routine procedures like a caesarean operation or a joint replacement will one day become be too risky to perform. The lives of cancer patients and others who undergo treatments that depress the immune system will equally be threatened.

We can stop the spread of resistance. Now is the time to re-establish or strengthen antibiotic stewardship programs to prevent misuse and overuse, and to ensure antibiotics are taken responsibly to effectively treat bacterial infections.

Further reading: Global Health Now
Author(s): MANICA BALASEGARAM. SOUHA S. KANJ
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!